In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

The wealth of Dr. Mehmet Oz, the celebrity heart surgeon nominated by President Donald Trump to lead the Centers for Medicare and Medicaid ...

Danaher, Recursion Pharmaceuticals, Moderna, Thermo Fisher Scientific, AbbVie, Vertex Pharmaceuticals, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...

Commenting on this year’s 2025 Best Workplaces in UAE™ list Mohammed AlShair, Executive Chairman of Great Place to Work® ...

The Vistria Group, LP ("Vistria"), a middle market private investment firm that seeks to deliver both superior financial returns and meaningful impact, today announced that Dr. Tony Coles, MPH will ...

AbbVie has secured its fourth FDA approval for Vraylar, adding adjunctive therapy of major depressive disorder (MDD) to a list that includes schizophrenia and manic and depressive episodes in ...

MM+M has revealed its 2025 Pinnacle Award honorees. The 21 members of this year’s Pinnacle class hail from a diverse range of health and wellness organizations, including pharma companies, medical ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

The rise of remote work is transforming real estate, driving demand for flexible workspaces, data centers, and suburban ...

YourBio Health, a pioneer in remote blood collection technology, announced today the appointments of Michael Mina, M.D., Ph.D. as Chief Scientific Officer, Chester Robson D.O., as Chief Medical ...